Ornithine decarboxylase (ODC) is under cell cycle control and increased ODC activity has been linked to both neoplasm and viral infection. ODC is an effective pharmacological target for the treatment of infections by Trypanosoma brucei. Remarkably, the mechanism of catalysis by ODC has not been clearly demonstrated nor is a structure known.
The specific aims of the proposed experiments are: (I) The mechanism of catalysis by ODC will be established as follows: (I.A) Mutagenesis will be utilized to stabilize or destabilize catalytic intermediates. (I.B) The reaction of orn with wild-type and mutant ODC's will be characterized using both CD and UV-visible stopped-flow spectroscopy. (I.C) The pH profile of mutant ODC's will be determined using both steady-state and stopped-flow techniques to correlate the rate constants for formation of individual chemical species with the chemistry of catalysis. (I.D) Solvent isotope effects will be used to help establish the mechanism of catalysis. (II) Two classes of mechanism-based ODC inhibitors will be synthesized and tested, (II.A) Bisubstrate analogs and (II.B) two potential suicide inhibitors.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32AI009495-02
Application #
2457673
Study Section
Tropical Medicine and Parasitology Study Section (TMP)
Project Start
1997-08-01
Project End
Budget Start
1997-08-01
Budget End
1998-07-31
Support Year
2
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Pharmacology
Type
Schools of Medicine
DUNS #
City
Dallas
State
TX
Country
United States
Zip Code
75390